Galectin Therapeutics Inc (NASDAQ:GALT) Investor Investigation
January 11, 2018 at 13:20 PM EST
San Diego, CA -- (SBWIRE) -- 01/11/2018 -- An investigation was announced for investors in NASDAQ:GALT shares over potential breaches of fiduciary duties by certain officers.
